Ex-U.S. contracting may be Tylenol's path of least resistance - FiercePharma Manufacturing

Ex-U.S. contracting may be Tylenol's path of least resistance - FiercePharma Manufacturing:

No matter how much money and horsepower you throw at it, pharma plant remediation is slow. The recent Wall Street Journal report disclosing Johnson & Johnson ($JNJ) had begun shipping Tylenol Cold & Flu Severe caplets after two years of incessant recalls has been confirmed by the company.

Read more: Ex-U.S. contracting may be Tylenol's path of least resistance - FiercePharma ...........................

'via Blog this'